Contribution of TIP30 to chemoresistance in laryngeal carcinoma

Author:

Zhu M,Yin F,Yang L,Chen S,Chen R,Zhou X,Jing W,Fan X,Jia R,Wang H,Zheng H,Zhao J,Guo Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Reference48 articles.

1. Wu YH, Tang PZ . Current opinions in therapeutics of advanced laryngeal carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28: 431–434.

2. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES . The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312–1317.

3. Mehta K . High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 1994; 58: 400–406.

4. Devarajan E, Chen J, Multani AS, Pathak S, Sahin AA, Mehta K . Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features. Int J Oncol 2002; 20: 913–920.

5. Kusumbe AP, Bapat SA . Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009; 69: 9245–9253.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3